Cases 21 - 30 of 262
BAUSCH HEALTH US, LLC et al v. MYLAN PHARMACEUTICALS INC. et al
as 3:2020cv02749
Plaintiff:
BAUSCH HEALTH IRELAND LIMITED, KAKEN PHARMACEUTICAL CO., LTD., BAUSCH HEALTH US, LLC and others
Defendant:
MYLAN PHARMACEUTICALS INC., MYLAN INC. and MYLAN LABORATORIES LTD.
Cause Of Action: 35 U.S.C. § 271
CELGENE CORPORATION v. MYLAN PHARMACEUTICALS INC. et al
as 2:2020cv02608
Plaintiff:
CELGENE CORPORATION
Defendant:
MYLAN PHARMACEUTICALS INC., MYLAN INC. and MYLAN N.V.
Cause Of Action: 15 U.S.C. § 1126
Boehringer Ingelheim Pharmaceuticals Inc. et al v. Mylan Pharmaceuticals Inc. et al
as 1:2020cv00019
Plaintiff:
Boehringer Ingelheim Corporation, Boehringer Ingelheim International GmbH, Boehringer Ingelheim Pharma GmbH & Co. KG and others
Defendant:
Mylan Pharmaceuticals Inc., Mylan Inc. and Mylan Laboratories Limited
Cause Of Action: 35 U.S.C. § 271
Celgene Corporation v. Mylan Pharmaceuticals Inc. et al
as 1:2020cv00003
Plaintiff:
Celgene Corporation
Defendant:
Mylan Pharmaceuticals Inc., Mylan Inc. and Mylan, N.V.
Cause Of Action: 35 U.S.C. § 145
CELGENE CORPORATION v. MYLAN PHARMACEUTICALS INC. et al
as 2:2019cv22231
Plaintiff:
CELGENE CORPORATION
Defendant:
MYLAN PHARMACEUTICALS INC., MYLAN INC. and MYLAN N.V.
Cause Of Action: 15 U.S.C. § 1126
AstraZeneca AB et al v. Mylan Pharmaceuticals Inc. et al
as 1:2019cv00203
Plaintiff:
Astrazeneca Pharmaceuticals LP and AstraZeneca AB
Defendant:
mylan inc., Mylan N.V., Mylan Laboratories Limited and others
Cause Of Action: 35 U.S.C. § 271
Novartis Pharmaceuticals Corporation v. Mylan Pharmaceuticals Inc. et al
as 1:2019cv00201
Defendant:
Mylan Laboratories Limited, Mylan Pharmaceuticals Inc. and Mylan Inc.
Plaintiff:
Novartis Pharmaceuticals Corporation
Cause Of Action: 35 U.S.C. § 271
Novartis Pharmaceuticals Corporation v. Dr. Reddys Laboratories, Inc. et al
as 1:2019cv02053
Defendant:
MSN Laboratories Private Limited, Dr. Reddys Laboratories, Inc., Hetero USA Inc. and others
Plaintiff:
Novartis Pharmaceuticals Corporation
Cause Of Action: 35 U.S.C. § 271
UCB, Inc. et al v. Mylan Technologies, Inc. et al
as 2:2019cv00148
Plaintiff:
UCB, Inc., LTS Lohmann Therapie-Systeme AG, UCB Pharma GmbH and others
Defendant:
Mylan Pharmaceuticals, Inc., Mylan Technologies, Inc. and Mylan, Inc.
Counter Claimant:
Mylan Technologies Inc.
Cause Of Action: 35 U.S.C. § 271
Merck Sharp & Dohme Corp. v. Mylan Pharmaceuticals Inc. et al
as 1:2019cv00101
Defendant:
Mylan Pharmaceuticals Inc. and Mylan Inc.
Plaintiff:
Merck Sharp & Dohme Corp.
Cause Of Action: 35 U.S.C. § 271
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.
